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Abstract
Rationale Acute tryptophan depletion (ATD) decreases
levels of central serotonin. ATD thus enables the cognitive
effects of serotonin to be studied, with implications for the
understanding of psychiatric conditions, including depression.
Objective To determine the role of serotonin in conscious
(explicit) and unconscious/incidental processing of emotional
information.
Materials and methods A randomized, double-blind, cross-
over design was used with 15 healthy female participants.
Subjective mood was recorded at baseline and after 4 h,
when participants performed an explicit emotional face
processing task, and a task eliciting unconscious processing
of emotionally aversive and neutral images presented
subliminally using backward masking.
Results ATD was associated with a robust reduction in
plasma tryptophan at 4 h but had no effect on mood or
autonomic physiology. ATD was associated with signifi-
cantly lower attractiveness ratings for happy faces and
attenuation of intensity/arousal ratings of angry faces. ATD
also reduced overall reaction times on the unconscious
perception task, but there was no interaction with
emotional content of masked stimuli. ATD did not affect
breakthrough perception (accuracy in identification) of
masked images.
Conclusions ATD attenuates the attractiveness of positive
faces and the negative intensity of threatening faces,
suggesting that serotonin contributes specifically to the
appraisal of the social salience of both positive and
negative salient social emotional cues. We found no
evidence that serotonin affects unconscious processing of
negative emotional stimuli. These novel findings implicate
serotonin in conscious aspects of active social and
behavioural engagement and extend knowledge regarding
the effects of ATD on emotional perception.
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Introduction
Serotonin (5-hydroxytryptamine, 5-HT) has been implicated
in human motivational behaviours and processes, including
affect regulation, impulse control, sexuality, appetite and
sleep. Serotonin dysfunction is also linked to a number of
psychiatric disorders, including depression (Caspi et al. 2003),
anxiety (Lesch et al. 1996), and schizophrenia (Juckel et al.
2008). In particular, the ‘serotonin hypothesis of depression’
proposes that a deficit in serotonergic activity either causes
or predisposes to major depression (Maes and Meltzer 1995).
Consistent with this, the majority of antidepressant drugs
enhance serotonergic activity (Blier and Bouchard 1994).
The contributions of serotonin to cognitive and emotional
processing can be inferred indirectly from studies of depressed
patients. However, acute depression is associated with the
confounds of negative biases in information processing,
affecting memory and attention (Bradley et al. 1995; MacLeod
et al. 1986) and face perception (Surguladze et al. 2004). The
effects of serotonin can be studied experimentally, without the
confound of low mood, using acute tryptophan depletion
(ATD), a well-established method to lower central 5-HT
levels (Nishizawa et al. 1997).
Several studies report that ATD in healthy people induces a
negative bias in emotional processing across experimental
paradigms, similar to that seen in depressed patients. For
example, ATD compromises memory for neutral and positive,
but not negative, words (Klaassen et al. 2002) and enhances
the interference effect of negative, but not positive, words in
emotional Stroop tasks (Evers et al. 2006). There is also
evidence that ATD selectively alters the processing of
emotional facial expressions: ATD is reported to decrease
recognition of fearful, but not other, facial expressions, in
healthy females (Harmer et al. 2003). Conversely, acute
administration of tryptophan may improve recognition of
emotional facial expressions (Attenburrow et al. 2003) and
administration of a selective serotonin re-uptake inhibitor
(SSRI) increases the recognition of facial fear cues (Harmer et
al. 2002). Face processing is particularly important to human
social cognition, as faces convey a rich variety of socially
relevant information beyond identity, gender and age, by also
signalling emotional state, intentions and sexual fitness. The
above considerations suggest that face processing may be one
route through which serotonin affects social cognition.
Stimuli processed below the threshold for conscious
awareness can significantly influence various aspects of
human behaviour (Kouider and Dehaene 2007). One of the
most established techniques for suppressing conscious aware-
ness of a stimulus is ‘backwardmasking’, where a target image
is presented very briefly (typically 20–40 ms) and is
immediately followed by the presentation of a distracter image
which ‘masks’, or blocks, the conscious processing of the
initial stimulus. Comparisons between conscious and uncon-
scious aspects of emotional processing provide insight into the
levels of processing at which behaviour is influenced. Existing
literature indicates that serotonin levels can influence mood
and explicit declarative emotion recognition.We explored first,
whether ATD was associated with tonic differences in
behavioural ratings and reaction time responses, and second
if ATD affected the reactivity of different axes of autonomic
bodily response to emotional stimuli. While characteristic
changes in autonomic tone (parasympathetic withdrawal) and
enhanced autonomic reactivity are reported in depression and
other psychiatric conditions (Bar et al. 2004; Bar et al. 2008),
there is a paucity of studies examining the effects of ATD on
visceral bodily responses.
To characterize further the role of serotonin in emotional
processing, to explore the levels of attention at which this
occurs and to investigate the physiological mechanisms which
might mediate these effects, we used double-blind, cross-over
ATD to temporarily reduce serotonin levels in 15 healthy
female volunteers. We examined performance during explicit
processing of emotional facial expressions and on a task
involving unconscious processing of aversive and neutral
stimuli, presented using backward masking. We recorded
evoked physiological changes in heart rate (inter-beat interval),
beat-to-beat blood pressure and electrodermal activity (skin
conductance response; SCR).
Our general prediction was that ATD would enhance
processing of negative stimuli. Specifically, we hypothesized
that ATDwould enhance the intensity of angry faces, based on
a prior study (Harmer et al. 2003). We also hypothesized that
ATD would be associated with differences in ratings for
attractiveness and valence for emotional faces (happy, angry
and sad). Further, we hypothesized that ATD would be
associated with differences in reaction times following the
presentation of negative, but not neutral, masked stimuli.
Finally, we hypothesized that ATD would be associated with
increased accuracy and confidence (or ‘breakthrough’) for
identification of negative but not neutral masked images.
Materials and methods
Participants
Twenty healthy female volunteers were recruited by email
advertisement. The study was approved by a local ethics
committee within the National Research Ethics Service.
Participants had been free from psychotropic medication for
at least 6 months, were not pregnant, and none declared a
personal or family history of major depression or any other
axis-I psychiatric disorder, as assessed by the a structured
interview drawn from appropriate screening items from the
structured clinical interview for the Diagnostic and Statistical
Manual of Mental Disorders III-R (DSM-III-R; American
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Psychiatric Association 1994; Spitzer et al. 1992). In addition,
participants completed a self-report health questionnaire
including questions on psychiatric disorders (Body Perception
Questionnaire; Porges 1993) and were interviewed by one of
the three authors who are psychiatrists. All volunteers gave
written informed consent before participating and were
financially compensated. One person vomited after ingesting
the drink and did not take part in the study. Four people did
not return for the second session, leaving 15 female volunteers
(mean age 23.4 years, range 19 to 34) whose data were
included in the analysis.
Tryptophan depletion protocol
Participants attended the lab on two occasions, representing
tryptophan depletion or the control states in a balanced
order, cross-over, randomized manner. The two sessions
were separated by 9 days on average (range 7–14 days). All
participants were tested in the follicular phase of their
menstrual cycle. Tryptophan depletion was induced by
standard method for women (Ellenbogen et al. 1996), using
a nutritionally balanced amino acid mixture containing:
L-alanine (4.58 g), L-arginine (4.08 g), L-cysteine (2.25 g),
glycine (2.25 g), L-histidine (2.67 g), L-isoleucine
(6.67 g), L-leucine (11.25 g), L-lysine monohydrochloride
(9.17 g), L-methionine (2.5 g), L-phenylalanine (4.75 g),
L-proline (10.17 g), L-serine (5.75 g), L-threonine (5.42 g),
L-tyrosine (5.75 g) and L-valine (7.42 g). The control
mixture additionally contained tryptophan (1.92 g). The
mixture was suspended in 300 ml of tap water and black-
currant flavour added (SHS International). Participants arrived
at the lab at 9 am, baseline blood was taken and participants
then drank the mixture at 9:15 am. Blood samples were
retaken 4 h later, in order to ensure a stable reduction in
tryptophan levels. Participants then completed the cognitive
assessment. Blood samples were allowed to clot, centrifuged
at 3,000 rpm at 4°C, for 10 min and stored at −80°C. Total
serum tryptophan was determined by fluorimetry.
Tasks
Images were presented centrally in a 400×400 pixel array on a
19″ LCD screen, in a dark, quiet experimental room. A
desktop computer was used to present the tasks and log the
behavioural responses, via a programme written on a Matlab
platform (Mathwork, Nantick MA). Two further sessions of a
separate study followed, which are not reported here.
The face processing task (see Fig. 1) was based on a task
previously described (Harrison et al. 2007). In brief, the
stimuli were colour photographs of angry, happy and sad faces
of 10 male and 10 female identities. Brightness, contrast and
luminosity were consistent across each face and emotional
expression. Images of faces were shown in random order with
each facial identity and emotion combination shown once.
Ratings were obtained sequentially for emotional intensity/
arousal, valence (negativity/positivity) and attractiveness, for
each face and emotion combination. Images remained on the
screen until each of the dimensions had been rated. Ratings
were inputted using a mouse-controlled cursor on a visual
analogue scale displayed on the screen. Ratings for attractive-
ness and intensity/arousal were constrained within the range 0
to 100, and for valence within the range −100 to 100. This was
a self-paced task and participants took approximately 25 min
on average to complete it.
In our second task (see Fig. 2) we explored unconscious
emotional processing by presenting target images very briefly
and backward masking them with other images (masks). We
generated a series of pictures to be used respectively as
masked pictures or masks. These images were pictures taken
from the International Affective Picture Set (IAPS; Lang et al.
2008) a set of affectively salient photographic images widely
used in experimental research. In brief, the stimuli were
colour photographs of emotionally neutral scenes (such as a
car or a field), or emotionally aversive scenes (such as a
severe facial deformity or a surgical scene). Masks and
masked pictures covered the full screen. Images were shown
in random order with each scene shown once. Masks and
target images both had a 50% probability of being either
aversive or neutral. Participants undertook two tasks both of
which comprised a precisely timed sequence. Thirty masked
images were presented for 26 ms (two screen refreshes) and
masks were presented for 1,000 ms, immediately following
each masked image. Participants were then asked to make
incidental judgements about whether the scene they had seen
was ‘indoors’ or ‘outdoors’. This task was novel, however our
backward masking methodology is well established. In our
task target images were presented for 26 ms, whereas
significant learning effects have been reported for visual
target durations as low as 10 ms (Zhang et al. 2009).
Following the completion of this task, participants were
asked whether or not they had noticed that images had been
presented very briefly before each mask. Participants took
approximately 7 min to complete the masking task.
In an extension of this masking task, it was explained to
participants that each picture they had seen in the previous
experimental run had been preceded by a very brief
presentation of another picture, some of which were neutral
and some of which were aversive. Participants then
underwent a further 26 trials, using different pictures but a
similar masking method as in task 2, and were also asked to
make the same incidental judgement of ‘indoors’ or
‘outdoors’. As for the first masking task, masks and target
images both had a 50% probability of being either aversive
or neutral. After each trial they were then presented with
two pictures presented side by side and given a forced
choice of which had been presented before the mask. For
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each trial participants then rated their confidence that their
choice had been correct, from 0 to 10. Participants took
approximately 9 min to complete this task.
Subjective rating scales
Before and after each session participants completed a number
of questionnaires. We quantified mood state with the Positive
Affect Negative Affect Schedule (PANAS; Watson et al.
1988), subjective anxiety levels using the Beck Anxiety
Inventory (BAI; The Psychological Corporation) and levels
of depression using the Beck Depression Inventory (BDI;
The Psychological Corporation). Drowsiness and dizziness
were also measured on a seven point Likert scale.
Physiological recording and analysis
Physiological measurements were recorded for each partici-
pant and for each trial. Heart rate (HR) and beat-to-beat
arterial pressure were recorded at the finger using a Finometer
(Finapres Medical Systems BV, Arnhem, The Netherlands).
We calculated heart rate variability (HRV) for the whole
length of each session. Skin conductance responses (SCRs)
were recorded from two Ag/AgCl electrodes applied to the
palmar surfaces of the participants’ second and fourth fingers
of the non-dominant hand.
Physiological measurements and event markers were
recorded at 100 Hz via an analogue-to-digital converter
(CED-Power1401) using the software Spike2 (v5; Cambridge
Electronic Design). The arterial pressure signal was pre-
processed with an algorithm which identified waveform peaks,
yielding systolic blood pressure (SBP) and inter-beat interval
(IBI). Baseline IBI and SBP were calculated for the 1,000 ms
time interval preceding the presentation of each image.
Changes in SBP and IBI were computed with respect to
baseline. First we calculated IBI and SBP for the first 4 beats
after baseline (i.e. beats 1, 2, 3 and 4), then we interpolated the
SBP and IBI data for the first 4 s time points after baseline (i.e.
seconds 1, 2, 3 and 4). We tested main effects of ATD on
physiological measures, separately for faces of different
valence, using paired-samples t tests for seconds 1, 2, 3 and
4 for cardiac physiology and for points of maximal difference
for SCRs.
Statistical analysis
Repeated-measures ANOVAs were used to assess main
effects of ATD on mood ratings (PANAS, BAI and BDI).
Further repeated-measures ANOVAswere used to assess main
effects of ATD and face emotion type (angry, happy, sad) on
behavioural ratings (attractiveness, intensity/arousal and
valence), and also interactions between the effect of ATD
negativity/positivity: 
0 --------- 0 -------- 100 
Time
1000 ms 
fixation 
1000 ms 
Face presentation 
Forced 
choice 
Forced 
choice 
Forced 
choice
intensity/arousal: 
0 --------- 50 -------- 100attractiveness: 
0 --------- 50 -------- 
 
100
+
Fig. 1 Schematic diagram of face task
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and emotion type on behavioural ratings. Similarly, for the
backward masking task, we used repeated-measures
ANOVAs to assess main effects, firstly of ATD and secondly
of target image type (aversive or neutral) on reaction times,
and also interactions between the effect of ATD and target
image type on reaction times. We also used separate repeated-
measures t tests to test the effects of ATD on behavioural
ratings for faces of different emotion types.
The arterial pressure signal was analysed for relative
percentages of high frequency (0.14–4 Hz; HF-HRV) and low
frequency (0.03–0.14 Hz; LF-HRV) heart rate variability
(HRV). As with previous papers from our lab (Beacher et al.
2009; Gray et al. 2009) HRV measures were assessed via an
autoregressive (AR) parametric model for spectrum estimation
(HRV analysis tool version 2.0 http://bsamig.uku.fi/index.
shtml, Department of Physics, University of Kuopio, Finland).
The SCR signal was low-pass filtered at 0.1 Hz and
polynomial detrended. The peak amplitude was determined for
the window 2–8 s from baseline. Baseline skin conductance
was calculated by averaging the skin conductance level during
the 2 s before the presentation of the task. Amplitude of the
SCRs was defined as the difference between the time-window
peak value and the baseline value.
For the explicit face processing task repeated-measures
ANOVAs were used to assess main effects of ATD and face
emotion type (angry, happy, sad) on the blood pressure levels
and amplitude of the SCRs, and also to assess interactions
between the effect of ATD and emotion type on these
physiological measures. Similarly, for the backward masking
task, we used repeated-measures ANOVAs to assess main
effects of ATD and target image type (aversive or neutral) on
physiological measures, and also interactions between the
effect of ATD and target image type on physiological measures.
We also used separate repeated-measures t tests to test the
effects of ATD on physiological measures for faces of different
emotion types.
The level of statistical significance was defined as p<0.05
(two tailed).
Results
Biochemical analysis
Serum tryptophan levels were reliably reduced by exposure to
depleted mixture vs. control (F1,14=155.2, p<0.001). Mean
indoors or 
outdoors? 
Press i or o
1000 ms 
fixation 
26 ms 
target 
Forced 
choice 1000 ms
mask 
Time 
+
Fig. 2 Schematic diagram of first masking task: masks and targets were aversive or neutral images
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change in tryptophan levels (±SEM) was −12.4 µg/ml
(±0.7) vs. 18.4 µg/ml (±2.3; t=−12.5, p<0.001) respec-
tively. These changes are consistent with previous reports
(Clark et al. 2005; Young et al. 1985). Mean tryptophan
levels under ATD were 15.6 µg/ml (±2.9) at baseline and
3.2 µg/ml (±0.92) at 4 h, and for the control condition
were 13.2 µg/ml (±1.1) at baseline and 31.7 µg/ml (±8.2)
at 4 h.
Questionnaire measures
There were no significant main effects, or trends to main
effects, of ATD on mood state, as measured by the PANAS,
BAI or BDI after 4 h (see Table 1). Similarly, we found no
significant order effects on measures of mood state, or
interactions between order and condition. Also, all partic-
ipants stated that they had no knowledge of which
treatment they had received.
Overall peripheral physiology
Additionally, there were no significant main effects of
ATD on the heart rate variability (HRV) indices recorded
across the entire experimental session. Mean parasympa-
thetic power (high frequency) was 32.9% (14.0%) under
ATD and 32.9% (13.1%) under the control condition.
Mean sympathetic power (low frequency) was 36.4%
(9.1%) under ATD and 37.6% (7.2%) under the control
condition. The mean ratio of low to high frequency
power was 0.30 (0.22) under ATD and 0.39 (0.25) under
the control condition. There were no outliers in the HRV
data.
Tasks
Explicit face processing task
Behavioural results As expected, there were highly
significant main effects of emotion type on subjective
ratings for attractiveness (F1,14=23.6, p<0.001), intensity
(F1,14=28.0, p<0.001) and valence (F1,14=161, p<0.001).
For a summary of effects of ATD on behavioural ratings
of faces see Table 2. Main effects of ATD on overall
behavioural ratings did not reach statistical significance,
however there was a trend for a main effects of ATD on
overall valence ratings (F1,14=3.4, p=0.09), with ATD being
associated with lower overall ratings for valence. We
examined interactions between ATD and emotion type for
behavioural ratings. There was a significant interaction
between ATD and emotion type for attractiveness ratings
(F1,14=4.0, p=0.046) but not for intensity/arousal or valence
ratings. To explore these effects further, we tested effects of
ATD separately on mean behavioural ratings for each
emotion type (angry, happy and sad), using separate paired
sample t tests. There was a significant effect of ATD on
mean attractiveness ratings for happy faces, but not angry or
sad faces, with ATD being associated with lower attractive-
ness ratings (t=−2.5, p=0.02; 4.6%; see Fig. 2). Also, there
was a significant effect of ATD on intensity/arousal ratings
for angry faces, but not happy or sad faces, with ATD
associated with lower intensity/arousal ratings (t=−2.6, p=
0.02; 4.3% difference; see Fig. 1). Ten of the fifteen
participants showed decreases in mean intensity/arousal
ratings for angry faces under ATD compared to the control
condition. There were no significant effects of ATD on mean
ratings for valence for either angry, happy or sad faces
considered separately.
Peripheral physiology There were no significant main
effects of ATD on overall evoked change in SBP or IBI
in response to faces of any emotion type. However, there
were significant main effects of emotion type on evoked
change in SBP for second 1 (F1,14=5.7, p=0.02) and
second 2 (F1,14=5.9, p=0.02), with angry faces being
associated with decreases in SBP relative to happy and sad
faces. There were no significant main effects of emotion
type on evoked change in IBI. There was also no significant
interaction between ATD and the effect of emotion type on
evoked change in SBP or IBI for any time point.
Further, there were no significant main effects of ATD
on evoked change in SCRs, for faces of any emotion type.
There was a significant main effect of emotion type on
evoked change in SCRs (F1,14=3.5, p=0.04), with happy
faces being associated with smaller decreases in SCRs,
relative to happy and sad faces. There was no significant
interaction between ATD and the effect of emotion type on
SCRs.
Thus ATD did not significantly affect overall behavioural
ratings, but ATD was associated with two specific effects:
significantly lower intensity/arousal ratings for angry faces
and significantly lower attractiveness ratings for happy faces
(Figs. 3 and 4).
There was no significant correlation between changes in
intensity ratings for angry faces and changes in attractiveness
ratings for happy faces (r=0.35; p=0.20). We found no
significant order effects, or trends for order effects.
Table 1 Questionnaire results
ATD Control F p
PANAS positive 22.9 (6.4) 24.3 (5.0) 2.7 0.1
PANAS negative 11.9 (2.8) 12.1 (2.0) 0.1 0.7
BAI (anxiety score) 7.3 (7.1) 7.8 (8.0) 0.2 0.7
BDI (depression score) 3.8 (4.9) 3.5 (4.6) 0.1 0.7
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Backward masking task
Behavioural results There was no significant main effect of
event type (aversive or neutral target) on reaction times.
There was a significant main effect of ATD on overall reaction
times, with ATD being associated with reduced reaction times
(t=−2.8, p=0.01; 31% difference). Mean reaction time under
ATD was 961 ms (SD=458 ms) and under the control
condition was 1,257 ms (SD=669 ms). There was no
significant interaction between ATD and event type on
reaction times. On completion of the first masking task,
thirteen of the fifteen participants (87%) answered ‘yes’ to
the question ‘Did you notice any pictures being flashed
BEFORE the main pictures?’.
% change in intensity ratings under
Fig. 3 ATD-related changes (%) on intensity/arousal ratings of angry
faces, showing significant ATD-related decrease in intensity ratings
for angry, but not happy or sad faces
Absolute change in attractiveness 
Fig. 4 ATD-related changes on attractiveness ratings, showing
significant ATD-related decrease in attractiveness ratings for happy,
but not angry or sad faces
Emotion type t p
Attractiveness overall 36.6 (10.1) 36.6 (9.2) 0.0 1
Intensity/arousal overall 61.5 (11.8) 63.1 (10.5) 2.4 0.1
Valence overall −11.9 (8.9) −14.2 (8.5) 3.4 0.09
Attractiveness ratings
Angry faces 26.4 (13.9) 25.3 (13.5) 1.4 0.2
Happy faces 54.1 (13.6) 56.7 (13.5) −2.6 0.02*
Sad faces 29.4 (11.4) 27.9 (10.6) 1.6 0.1
Intensity/arousal
Angry faces 72.0 (11.1) 75.2 (9.8) −2.6 0.02*
Happy faces 54.4 (20.3) 54.4 (20.2) 0.1 0.9
Sad faces 58.2 (11.8) 59.7 (11.2) 0.9 0.3
Valence
Angry faces −52.4 (15.6) −57.4 (18.0) 3.0 0.1
Happy faces 61.3 (14.6) 62.8 (16.7) 0.3 0.6
Sad faces −43.6 (16.0) −47.9 (12.6) 1.7 0.2
Table 2 Results for facial
emotion task: means and
standard deviations for
behavioural ratings
* 5% (0.05)
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In the second ‘identification’ masking task, all but one of
the participants had an overall accuracy (averaging over
both conditions) which was above chance, and in six of the
fifteen participants (40%) this was significantly above
chance. However, in only one of the fifteen participants
there was a significant positive correlation between overall
accuracy and overall confidence, over all trials. This
suggests that perception of masked pictures involved a
measurable degree of conscious awareness for this one
participant, but not for other participants. Thus, we provide
evidence that that the first masking task (which used the
same masking procedure) successfully induced learning of
masked target images and also (due to the lack of
significant correlation between accuracy and confidence)
that the perception of the masked target images was not
conscious.
There were no significant main effects of ATD on accuracy
or confidence for judgment of masked stimuli, for either
aversive-neutral or neutral-neutral trials. However, there was a
trend for an ATD-related decrease in overall confidence rating
for judgments of aversive-neutral trials (t=−2.1, p=0.08).
There were no significant main effects of event type, or
significant interaction between ATD and event type, on
accuracy or confidence. For both ATD and control con-
ditions there were no significant correlations between
reaction times, accuracy and confidence.
Peripheral physiology For the backward masking task,
there were no significant main effects of event type
(aversive or neutral target) or ATD on evoked SBP or IBI,
for any time point. Further, there were no significant
interactions between ATD and event type on evoked SBP
or IBI.
Order effects
One shortcoming of a within-subject design is that practice
effects pose a potential confound. To address this potential
problem, we tested whether there were significant main effects
of ATD order on relevant factors. For the face task these were
overall ratings for attractiveness, intensity/arousal and valence,
and also event-related SBP, IBI and SCRs. For the backward
masking task these were reaction times, accuracy, confidence
and event-related SBP and IBI. We found no significant order
effects, or trends for order effects.
Discussion
We found that ATD was not associated with a general
negative cognitive bias: ATD was not associated with
significant overall differences in ratings for faces in terms
of attractiveness or positivity/negativity. Also, we did not
find that ATD was associated with decreases in mood state.
Some prior reports have reported that ATD leads to mood
lowering IN HEALTHY SUBJECTS, however, considering
the literature as a whole, these effects are either modest or
non-significant (Bell et al. 2005), therefore this finding is
consistent with the literature. However, as predicted, we
found specific modulatory effects of ATD on emotion
processing. ATD elicited significantly lower intensity/
arousal ratings for angry (but not happy or sad) faces,
although the magnitude of this effect was modest (4.3%).
We also found that ATD diminished attractiveness ratings
for positive happy faces. In the backwards masking task
ATD did not affect the unconscious processing of negative,
relative to neutral, emotional stimuli. Also, while there was
an overall enhancement of psychomotor responsivity (faster
reaction times) in this task, there was no enhanced
awareness or identification of masked aversive images,
suggesting that this was not an effect of perceptual
attention. ATD was not associated with overall differences
in physiological measurements or difference in evoked
physiological responses, following either emotional faces or
masked images. In sum, these findings suggest a specific
effect of ATD on the conscious appraisal of socially salient
information from faces, implicating serotonin in reinforce-
ment of affective engagement to relevant, consciously
perceived cues. The effects we report occurred without
confounding changes in autonomic or mood state, anxiety
level or drowsiness. Our results add to the observations of
previous studies which have suggested a role for serotonin in
emotional functioning, and dissect specific aspects of cogni-
tive/emotional function which are affected in ATD.
Our finding that ATD was associated with lower intensity/
arousal ratings for angry (but not happy or sad) faces extends
the suggestion that serotonin has a specific role in the
processing of fear and threat (Hellewell et al. 1999). A prior
study reported that ATD decreased the declarative recognition
of fearful facial expressions (Harmer et al. 2003). Conversely,
acute administration of citalopram (a serotonin reuptake
inhibitor) and dietary tryptophan is reported to enhance
recognition of fearful faces (Attenburrow et al. 2003; Harmer
et al. 2002). These categorical effects on expression recogni-
tion may be partly dissociated from judgments of perceived
emotional intensity, the latter reflecting the impact or salience
of the expression on the observer. Here we found that the
subjective impact of another’s anger is blunted as a conse-
quence of depleted serotonin level. This observation is not
confined to processing threat. Taking attractiveness ratings as
a proxy for the willingness approach an individual with a
positive expression, again ATD blunted this dimension of
social salience. Together these effects on face perception
suggest that serotonin enhances conscious evaluation of
signals particular to social approach irrespective of valence.
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Consistent with this is the lack of an effect on sad faces, which
intrinsically communicate social disengagement (sensitivity to
this is nevertheless related to empathy (Harrison et al. 2006;
Harrison et al. 2007)). Differences in facial emotion process-
ing are reported to predict relapse in depressed patients
(Bouhuys et al. 1999). One extension of our study would be to
examine whether differences in face processing similar to
those we report are present in depressed patients, and whether
such differences may constitute a significant component of the
cognitive substrates of depression. Linking serotonin action
specifically to the processing cues for social motivation and
interpersonal engagement has broader clinical relevance, for
example in schizophrenia. Motivational and social deficits
characterize negative schizophrenic symptomatology. Atypi-
cal antipsychotics such as clozapine act on serotonergic, as
well as dopaminergic, pathways (Leysen et al. 1994) and
appear, in contrast to classical neuroleptic medications, to be
more effective in treating the negative, as well as the
positive, symptoms of schizophrenia. However, this is not
firmly established (Salimi et al. 2009) and more knowledge
of how antipsychotic blockade of subtypes of serotonin
receptors might facilitate the potentially prosocial effects we
attribute to serotonin from our ATD study.
The present study is the first, to our knowledge, to explore
how serotonergic function relates to the unconscious process-
ing of aversive information. ATD did not increase the detection
accuracy of masked aversive images, thus showing that
serotonin depletion did not enhance the negative salience
(‘attentional grab’) of unconscious visual threat stimuli. ATD
was, however, associated with enhanced psychomotor respon-
sivity (faster reaction times) across all stimulus types. This
finding is consistent with prior studies that report improve-
ments in focused attention following ATD (Coull et al. 1995;
Schmitt et al. 2000), although the overall evidence for such
an effect is somewhat inconsistent (Mendelsohn et al. 2009).
Our data suggest this effect is operating at the level of
volitional ‘conscious’ engagement with the task, rather than
at a lower level of peripheral reactivity, since we found no
effects of ATD on tonic or reactive autonomic measures that
would represent signatures of a somatic state of enhanced
motoric and behavioural reactivity.
Masking studies typically assume the binary distinction
between conscious and unconscious processing, based on
declarative recall but this approach is problematic
(Lovibond and Shanks 2002). The threshold of explicit
processing is blurred (Wiens 2006) and this is what we
address particularly within the perceptual breakthrough
(second backward masking) experiment. Together our
experiments address the effects of ATD on unconscious
processing of affective and neutral stimuli (i.e. masked
images not recognized in forced choice), shifts in detection
of rapidly presented affective and neutral stimuli (break-
through) and, in the first experiment, declarative ratings of
perceived stimuli. In so doing we feel we can take a view
within the limits of experimental design about the role of
serotonin in conscious and unconscious processing, sug-
gesting, as above, that observed effects appear to be
expressed for explicit, rather than implicit, processes. We
acknowledge a potential limitation of our task: We did not
find an effect of emotion type (aversive vs. neutral) on
reaction times, suggesting that our task may be relatively
insensitive to measure implicit processing. We therefore
cannot exclude the possibility that serotonin is involved in
aspects of unconscious emotional processing but we failed
to detect evidence for this.
Ultimately our findings suggest that serotonin may not
have a major contribution to unconscious reactions and
processing of negative information. It has been proposed
theoretically that serotonin has an opponent relationship to
dopaminergic signals in behavioural and motivational
learning, reflecting long-run average rates of presentation
of appetitive stimuli (Daw et al. 2002). While our findings
do not contradict this long term model, they suggest an
additional short term role in explicit appraisal of motiva-
tional salience that is not tied to the valence of stimuli. An
important goal of future studies is to extend this experi-
mental work to examine comparatively the effects of
dopaminergic and noradrenergic manipulation on social
approach/withdrawal in humans.
The absence of an effect of ATD on autonomic responses
has implications for understanding and management of
biological symptoms of affective disorders. We found that
ATD was not associated with differences on overall or evoked
cardiovascular or electrodermal response to the presentation of
emotional visual stimuli, either emotional faces or masked
aversive images. Further, ATD was not associated with
differences in tonic autonomic measurements. This implies
that the effects we report (including that of reaction time
facilitation) are not mediated via the autonomic nervous
system. Serotonergic and autonomic functions are related; for
example mice that lack serotonin in the central nervous system
show decreased blood pressure and heart rate (Alenina et al.
2009). Also, many patients with depression show autonomic
dysfunction, for example in lowered heart rate variability (Licht
et al. 2008) and increased sympathetic tone (Veith et al. 1994),
and similar findings are reported in schizophrenia (Bar et al.
2008). Further, SSRI treatment impacts on vegetative function
and autonomic reactivity (Koschke et al. 2009). However,
these autonomic changes may be mediated indirectly through
other neurotransmitter systems, in particular noradrenergic
neurotransmission (Li et al. 2009; Samuels and Szabadi 2008).
In the current study, we did not observe alterations in
basal or evoked cardiac response (heart rate or HRV)
following ATD. Previous studies also report no effects on
resting or background cardiovascular autonomic tone (e.g.
van der Veen et al. 2008) but nevertheless show effects of
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ATD on autonomic reactions to receiving feedback on error
trials cognitive tasks. For example, ATD may attenuate
cardiac deceleration when informed of errors in time
estimation (van der Veen et al. 2008) and flanker tasks
(Van der Veen et al. 2009). These suggest diminished
cognitive processing of error following ATD (Cools et al.
2008). Direct effects of serotonin on cardiovascular function
are suggested in case reported of clinically-significant
bradycardia in (atypical) anxiety patients following ATD
(Hood et al. 2010), consistent with a serotonergic effect
within brainstem baroreflex nuclei (Bago and Dean 2001;
Davies et al. 2007). However, we note that our experiments
did not embody aspects of monitoring and error-feedback for
shaping subsequent task performance and our results suggest
that affective processing without these factors does not have
a critical serotonin-dependent autonomic component. Also,
our female participants had no previous history of clinical
anxiety or cardiac dysfunction, and therefore no pathological
HR or HRV responses to ATD were observed.
In the current study we did not observe alterations in basal or
evoked cardiac response (heart rate or HRV) following ATD.
Previous studies also report no effects on resting or background
cardiovascular autonomic tone (e.g. van der Veen et al. 2008)
but nevertheless show effects of ATD on autonomic reactions
to receiving feedback about performance error during cogni-
tive tasks. For example, ATD may attenuate cardiac deceler-
ation associated with errors in time estimation (van der Veen et
al. 2008) and flanker tasks (Van der Veen et al. 2009). These
suggest diminished processing of negative error information
following ATD (Cools et al. 2008). Direct effects of serotonin
on cardiovascular function are suggested by case reports of
clinically-significant bradycardia in (atypical) anxiety patients
following ATD (Hood et al. 2010), and by changes in HRV
following SSRI treatment (Licht et al. 2008). These findings
are consistent with a serotonergic effect within brainstem
baroreflex nuclei (Bago and Dean 2001; Davies et al. 2007).
However, in the absence of mood disorder or negative
feedback serotonergic modulation does not appear to impact
on cardiovascular autonomic control.
Summary
In summary, our results suggest that, within healthy females,
acute decreases in serotonin lead to modest specific differ-
ences in the processing of emotional facial expressions, and
enhanced psychomotor reactivity. We found no evidence that
decreases in serotonin affect detection of emotionally aversive
and neutral masked images. Our findings help to characterize
the role of serotonergic function in emotional processing. Our
results complement previous findings suggesting that the
effect of serotonin on fear perception is mediated via effect on
perceived intensity of facial expressions.
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